Portfolio data

Browse all portfolio data news

Search

Latest portfolio data news

Show news from

all companies
all Late-stage clinical companies companies
all Clinical companies companies
iOnctura
all Pre-clinical companies companies

08.05.25

iOnctura commences randomised Phase I/II study in non-small cell lung cancer

Clinical companies
iOnctura

20.03.25

iOnctura commences randomized Phase II study in metastatic uveal melanoma

Clinical companies
iOnctura

11.12.24

iOnctura reaches new clinical milestones in uveal melanoma

Clinical companies
iOnctura

Sign-up for company news alerts

Get the latest RNS, company news, share price information and results from Syncona

RNS alerts
Company alerts

Syncona Investment Management Limited
2nd Floor
8 Bloomsbury Street
London
WC1B 3SR

contact@synconaltd.com

About
Our people
Portfolio
Sustainability
The Foundation
News & insights
Investors
Contact

Accessibility
Privacy & cookies
Employee privacy notice
Third party privacy notice
Regulatory publications
Modern slavery statement

Syncona Limited is registered in Guernsey no. 55514, registered office Frances House, PO Box 273, Sir William Place, St. Peter Port, Guernsey, GY1 3RD.
Syncona Investment Management Limited is registered in England no. 10497864, 8 Bloomsbury Street, London WC1B 3SR and is authorised and regulated by the FCA. Syncona Limited is managed by Syncona Investment Management Limited.

threethirty.studio

About
Our people
Portfolio
Sustainability
The Foundation
News & insights
Investors
Contact

GBX 88.50

Change: +0.90 (+1.03%)

Search